Inspiration Healthcare has reported interim results for the 6 months to 31 July 2019. Trading in the period was in-line with expectations, with revenue growth of 9% delivered by both domestic and international sales. Own Brand growth of 13% supported gross margin expansion to 46.8%, while products launched in the last 24 months contributed 17% of revenues. We believe the group remains on track to deliver double-digit revenue growth in FY20E and maintain our Buy recommendation.
02 Oct 2019
Cenkos: Inspiration Healthcare Group Plc - Astute investment delivering
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Cenkos: Inspiration Healthcare Group Plc - Astute investment delivering
Inspiration Healthcare Group PLC (IHC:LON) | 28.5 0 0.0% | Mkt Cap: 19.4m
- Published:
02 Oct 2019 -
Author:
Chris Donnellan -
Pages:
6
Inspiration Healthcare has reported interim results for the 6 months to 31 July 2019. Trading in the period was in-line with expectations, with revenue growth of 9% delivered by both domestic and international sales. Own Brand growth of 13% supported gross margin expansion to 46.8%, while products launched in the last 24 months contributed 17% of revenues. We believe the group remains on track to deliver double-digit revenue growth in FY20E and maintain our Buy recommendation.